Keiji Yoshimura
Direktor/Vorstandsmitglied bei Oncolys USA, Inc.
Vermögen: 79 497 $ am 30.04.2024
Profil
Keiji Yoshimura is currently the Director at Oncolys USA, Inc. He previously worked as the Director, Manager-Accounting & Head-Administration at Oncolys BioPharma, Inc. from 2019 to 2021.
Before that, he served as the Chief Financial Officer at Gosen Co., Ltd.
and Taiko Paper Mfg., Ltd.
He also worked as a Finance Manager at Amgen KK.
Mr. Yoshimura completed his undergraduate degree in Economics from Senshu University School of Economics in 1979.
He also holds an undergraduate degree from Shiga Prefectural Yokaichi High School, which he obtained in 1974.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ONCOLYS BIOPHARMA, INC.
0,09% | 31.12.2022 | 18 000 ( 0,09% ) | 79 497 $ | 30.04.2024 |
Aktive Positionen von Keiji Yoshimura
Unternehmen | Position | Beginn |
---|---|---|
Oncolys USA, Inc. | Direktor/Vorstandsmitglied | 01.08.2016 |
Ehemalige bekannte Positionen von Keiji Yoshimura
Unternehmen | Position | Ende |
---|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Finanzdirektor/CFO | - |
Gosen Co., Ltd.
Gosen Co., Ltd. Recreational ProductsConsumer Durables Part of The Japan Wool Textile Co., Ltd., Gosen Co., Ltd. is a Japanese company that manufactures and markets sporting and fishing goods and textile products. The company is based in Osaka, Japan. Gosen Co. was acquired by The Japan Wool Textile Co., Ltd. from Synergy Capital Co., Ltd. on August 31, 2006. | Finanzdirektor/CFO | - |
Taiko Paper Mfg., Ltd.
Taiko Paper Mfg., Ltd. Pulp & PaperProcess Industries Taiko Paper Mfg Ltd. manufactures and supplies functional and specialty paper. It supplies machine-finish specialty paper and one-side glazed kraft paper for industrial use. The firm also produces functional papers for household products. The company was founded in June 1950 and is headquartered in Fuji, Japan. | Finanzdirektor/CFO | - |
ONCOLYS BIOPHARMA INC. | Verwaltungsdirektor | 01.04.2021 |
Ausbildung von Keiji Yoshimura
Senshu University School of Economics | Undergraduate Degree |
Shiga Prefectural Yokaichi High School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ONCOLYS BIOPHARMA INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Gosen Co., Ltd.
Gosen Co., Ltd. Recreational ProductsConsumer Durables Part of The Japan Wool Textile Co., Ltd., Gosen Co., Ltd. is a Japanese company that manufactures and markets sporting and fishing goods and textile products. The company is based in Osaka, Japan. Gosen Co. was acquired by The Japan Wool Textile Co., Ltd. from Synergy Capital Co., Ltd. on August 31, 2006. | Consumer Durables |
Taiko Paper Mfg., Ltd.
Taiko Paper Mfg., Ltd. Pulp & PaperProcess Industries Taiko Paper Mfg Ltd. manufactures and supplies functional and specialty paper. It supplies machine-finish specialty paper and one-side glazed kraft paper for industrial use. The firm also produces functional papers for household products. The company was founded in June 1950 and is headquartered in Fuji, Japan. | Process Industries |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Oncolys USA, Inc. |